It has been found that CD10 and GPR77 can define human CAF subpopulations, and CAF subsets with high expression of CD10 and GPR77 are related to chemotherapy resistance and poor prognosis in patients with lung and breast cancer. This evidence concerns the gene MME and breast carcinoma.